Magellan Health Inc (NASDAQ:MGLN) CEO Mostafa Kamal sold 2,180 shares of the firm’s stock in a transaction that occurred on Monday, December 4th. The shares were sold at an average price of $92.00, for a total transaction of $200,560.00. Following the completion of the sale, the chief executive officer now owns 2,180 shares in the company, valued at approximately $200,560. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.

Mostafa Kamal also recently made the following trade(s):

  • On Wednesday, November 1st, Mostafa Kamal sold 1,154 shares of Magellan Health stock. The shares were sold at an average price of $92.00, for a total transaction of $106,168.00.
  • On Thursday, September 28th, Mostafa Kamal sold 4,848 shares of Magellan Health stock. The shares were sold at an average price of $85.76, for a total transaction of $415,764.48.
  • On Wednesday, September 27th, Mostafa Kamal sold 19,126 shares of Magellan Health stock. The shares were sold at an average price of $85.33, for a total transaction of $1,632,021.58.
  • On Friday, September 15th, Mostafa Kamal sold 2,961 shares of Magellan Health stock. The shares were sold at an average price of $84.00, for a total transaction of $248,724.00.
  • On Wednesday, September 13th, Mostafa Kamal sold 604 shares of Magellan Health stock. The stock was sold at an average price of $83.00, for a total transaction of $50,132.00.
  • On Monday, September 11th, Mostafa Kamal sold 670 shares of Magellan Health stock. The stock was sold at an average price of $83.00, for a total transaction of $55,610.00.
  • On Friday, September 8th, Mostafa Kamal sold 6,267 shares of Magellan Health stock. The stock was sold at an average price of $81.53, for a total transaction of $510,948.51.
  • On Thursday, September 7th, Mostafa Kamal sold 2,190 shares of Magellan Health stock. The stock was sold at an average price of $81.07, for a total transaction of $177,543.30.

Shares of Magellan Health Inc (NASDAQ MGLN) traded up $0.45 during midday trading on Wednesday, reaching $95.70. 173,900 shares of the company were exchanged, compared to its average volume of 143,662. Magellan Health Inc has a fifty-two week low of $64.05 and a fifty-two week high of $95.90. The company has a market capitalization of $2,290.03, a P/E ratio of 21.70, a PEG ratio of 1.22 and a beta of 0.54. The company has a debt-to-equity ratio of 0.62, a current ratio of 2.28 and a quick ratio of 2.21.

Magellan Health (NASDAQ:MGLN) last announced its earnings results on Wednesday, November 1st. The company reported $1.64 earnings per share for the quarter, topping analysts’ consensus estimates of $1.40 by $0.24. Magellan Health had a net margin of 1.68% and a return on equity of 9.20%. The business had revenue of $1.42 billion during the quarter, compared to the consensus estimate of $1.49 billion. During the same quarter last year, the firm earned $1.39 earnings per share. Magellan Health’s quarterly revenue was up 9.9% on a year-over-year basis. analysts anticipate that Magellan Health Inc will post 5.19 earnings per share for the current year.

A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. California Public Employees Retirement System raised its stake in Magellan Health by 1.3% during the third quarter. California Public Employees Retirement System now owns 81,744 shares of the company’s stock worth $7,055,000 after buying an additional 1,044 shares during the last quarter. Cubist Systematic Strategies LLC raised its stake in Magellan Health by 54.8% during the third quarter. Cubist Systematic Strategies LLC now owns 6,766 shares of the company’s stock worth $584,000 after buying an additional 2,395 shares during the last quarter. Cornerstone Capital Management Holdings LLC. bought a new position in Magellan Health during the third quarter worth $870,000. KBC Group NV raised its stake in Magellan Health by 22.0% during the third quarter. KBC Group NV now owns 26,298 shares of the company’s stock worth $2,270,000 after buying an additional 4,736 shares during the last quarter. Finally, Hillsdale Investment Management Inc. raised its stake in Magellan Health by 7.4% during the third quarter. Hillsdale Investment Management Inc. now owns 14,500 shares of the company’s stock worth $1,251,000 after buying an additional 1,000 shares during the last quarter. 94.96% of the stock is owned by institutional investors and hedge funds.

A number of equities analysts have recently commented on MGLN shares. Jefferies Group reiterated a “buy” rating and set a $94.00 price target on shares of Magellan Health in a report on Friday, October 13th. BidaskClub upgraded shares of Magellan Health from a “sell” rating to a “hold” rating in a report on Tuesday, August 8th. KeyCorp set a $105.00 price target on shares of Magellan Health and gave the stock a “buy” rating in a report on Friday, December 1st. Raymond James Financial reiterated a “hold” rating on shares of Magellan Health in a report on Saturday. Finally, Zacks Investment Research lowered shares of Magellan Health from a “buy” rating to a “hold” rating in a report on Wednesday, October 4th. Three equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company. The stock presently has a consensus rating of “Buy” and an average target price of $90.50.

WARNING: “Mostafa Kamal Sells 2,180 Shares of Magellan Health Inc (MGLN) Stock” was first posted by American Banking News and is owned by of American Banking News. If you are reading this piece on another publication, it was copied illegally and reposted in violation of U.S. & international copyright & trademark law. The original version of this piece can be viewed at https://www.americanbankingnews.com/2017/12/06/mostafa-kamal-sells-2180-shares-of-magellan-health-inc-mgln-stock.html.

About Magellan Health

Magellan Health, Inc is engaged in the healthcare management business. The Company’s segments include Healthcare, Pharmacy Management and Corporate. It is focused on managing special populations, complete pharmacy benefits and other specialty areas of healthcare. Its Healthcare includes its management of behavioral healthcare services and employee assistance program (EAP) services, management of other specialty areas, including diagnostic imaging and musculoskeletal management, and the integrated management of physical, behavioral and pharmaceutical healthcare for special populations, delivered through Magellan Complete Care (MCC).

Insider Buying and Selling by Quarter for Magellan Health (NASDAQ:MGLN)

Receive News & Ratings for Magellan Health Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Magellan Health Inc and related companies with MarketBeat.com's FREE daily email newsletter.